Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-25-006040
Filing Date
2025-05-22
Accepted
2025-05-22 16:53:00
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 cvm_424b5.htm 424B5 511150
2 cvm_424b5img22.jpg GRAPHIC 36433
3 cvm_424b5img21.jpg GRAPHIC 31976
4 cvm_424b5img18.jpg GRAPHIC 43456
5 cvm_424b5img17.jpg GRAPHIC 33798
6 cvm_424b5img16.jpg GRAPHIC 22107
7 cvm_424b5img15.jpg GRAPHIC 22089
8 cvm_424b5img14.jpg GRAPHIC 22109
9 cvm_424b5img11.jpg GRAPHIC 6765
10 cvm_424b5img10.jpg GRAPHIC 4565
  Complete submission text file 0001654954-25-006040.txt   820857
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-265995 | Film No.: 25977975
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)